Neuropsychiatria i Neuropsychologia is a pivotal journal dedicated to the exploration of behavioral neuroscience, neuropsychology, and psychiatry, published by TERMEDIA PUBLISHING HOUSE LTD in Poland. This journal, with an ISSN of 1896-6764, has been a significant contribution to the scientific community since its inception in 2009 and continues to converge its findings until 2024. While it operates under a traditional access model, its commitment to disseminating research in these critical fields is unwavering. The journal currently holds a Q4 classification in multiple categories including Behavioral Neuroscience and Neuropsychology, reflecting its growing influence in the landscape of mental health studies. With Scopus rankings displaying a percentile standing in the bottom quartile, Neuropsychiatria i Neuropsychologia presents an opportunity for authors and researchers to contribute and engage with emerging findings in psychiatry and behavioral science. By fostering scholarly communication and collaboration, this journal serves as a valuable resource for researchers, professionals, and students seeking to advance their understanding and knowledge within these vital areas of study.

Neuropeptides is a prestigious, peer-reviewed journal published by Elsevier, focusing on the critical role of neuropeptides in various biological processes and their implications in cellular and molecular neuroscience, endocrinology, and neurology. With an impact factor reflecting its influence in the field and a diverse audience ranging from researchers to healthcare professionals, the journal serves as an essential platform for the dissemination of groundbreaking research from 1980 to 2024. Adhering to high academic standards, Neuropeptides holds a Q3 ranking in Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems, alongside a solid Q2 ranking in both Endocrinology and Neurology. This positions the journal at the forefront of its disciplines, contributing valuable insights into the understanding of neuropeptide functions in health and disease. By not operating as an Open Access journal, it ensures sustainability in the publishing process while upholding rigorous review standards. Researchers, professionals, and students are encouraged to engage with the findings published in this journal, which plays a vital role in advancing knowledge and fostering collaboration within the neuroscientific community.

SCHIZOPHRENIA BULLETIN, published by Oxford University Press, stands as a leading journal in the field of psychiatry and mental health, particularly focusing on the complexities of schizophrenia. Established in 1973, this esteemed journal covers a wide spectrum of research areas, including clinical findings, neurobiology, epidemiology, and treatment approaches, making it indispensable for researchers and practitioners alike. With its current status in the Q1 category of the psychiatry and mental health disciplines, and a remarkable Scopus rank of #34 out of 567, the journal enjoys a strong impact factor, emphasizing its contribution to advancing knowledge in mental health. Although it operates on a subscription model, the significance of the journal in disseminating groundbreaking research makes it a vital resource for those committed to improving outcomes in schizophrenia. Through its rigorous peer-review process and commitment to high-quality scientific communication, SCHIZOPHRENIA BULLETIN continues to be at the forefront of psychiatric research and discourse.

Cognition, published by Elsevier, is a leading journal dedicated to the exploration and advancement of knowledge in the multifaceted fields of cognitive neuroscience, cognitive psychology, and linguistics. Since its inception in 1972, this prestigious journal has established itself as a prominent platform for disseminating innovative research and critical reviews, achieving a remarkable Q1 ranking across various relevant categories, including Cognitive Neuroscience and Developmental Psychology, as per the 2023 metrics. With a focus on providing insights that are vital for researchers, professionals, and students alike, Cognition boasts an impressive standing in the academic community, evidenced by its high Scopus rankings which place it in the top percentiles in several disciplines. Researchers interested in the cognitive processes underlying human thought, language, and behavior will find Cognition an invaluable resource that publishes cutting-edge findings and fosters interdisciplinary collaboration. Though it operates under a traditional access model, the breadth and depth of its content ensure it remains integral to advancing cognitive science.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

Behavioural Pharmacology is a distinguished academic journal published by Lippincott Williams & Wilkins, focusing on the intricate relationship between pharmacology, psychiatry, and behavioral science. With an ISSN of 0955-8810 and an E-ISSN of 1473-5849, this journal serves as a vital platform for researchers and professionals dedicated to exploring the pharmacological mechanisms underlying behavior and mental health. Operating with a robust track record since its inception in 1992, it has established itself in the academic community, as reflected by its Q3 rankings in both the pharmacology and psychiatry categories for 2023. Additionally, the journal holds a credible position in Scopus rankings, with a percentile ranking indicative of significant contributions to the fields of pharmacology and psychiatry. Aimed at advancing knowledge and disseminating research in the behavioral pharmacology domain, this journal is an essential resource for students, researchers, and clinical professionals seeking to stay at the forefront of this rapidly evolving field. While it is not an open access journal, the rich content and research findings published here continue to foster collaboration and innovation within the community, making it a crucial reference point for current and future studies.

FRONTIERS IN NEUROENDOCRINOLOGY, published by Academic Press Inc, Elsevier Science, is a leading peer-reviewed journal dedicated to advancing the understanding of neuroendocrinology, focusing on the intricate interactions between the nervous system and endocrine functions. Established in 1973, this esteemed publication has consistently demonstrated its significance in the field, achieving a category quartile ranking of Q1 in Endocrine and Autonomic Systems for 2023, and securing a remarkable 93rd percentile in the Scopus Rankings. Though the journal is not open-access, it is widely recognized for its high-quality research articles that provide crucial insights into the neuroendocrine mechanisms underlying various physiological processes and disorders. As it continues to bridge gaps in knowledge from 1990 through to 2024, FRONTIERS IN NEUROENDOCRINOLOGY is essential for researchers, professionals, and students alike, aiming to foster collaboration and innovation within the dynamic landscape of neuroendocrine science.

PSYCHOPHYSIOLOGY, published by WILEY, stands as a leading journal in the intersection of psychology and physiology, contributing significantly to our understanding of the brain and body connection since its inception in 1964. With an impressive scope covering areas such as biological psychiatry, cognitive neuroscience, and neuropsychology among others, the journal has earned multiple Q1 rankings in these critical domains as of 2023, reflecting its high impact in the field. The journal ranks particularly well in categories such as Experimental and Cognitive Psychology and neurology, indicating its status as a pivotal resource for professionals and researchers committed to advancing knowledge in psychophysiological studies. Furthermore, with an e-ISSN of 1469-8986, PSYCHOPHYSIOLOGY is accessible to a global audience, although it is not part of the Open Access movement, ensuring that its rigorous research remains a trusted source for academic excellence. By engaging with this journal, readers can expect to discover pioneering research and significant findings that push the boundaries of current understanding, making it an essential publication for those invested in the advancements of psychological and physiological sciences.

STRESS - THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing our understanding of stress and its biological underpinnings. Established in 1996 and continuing until 2024, this journal is pivotal in the exploration of stress across multiple dimensions, including its impact on mental health, neurobiology, and endocrine systems. With an impressive categorization in Q2 and Q3 quartiles across various fields such as Behavioral Neuroscience, Psychiatry, and Physiology, STRESS ranks commendably within its discipline, positioning itself as a vital resource for researchers and professionals alike. As of 2022, the journal's open access policy enhances visibility and accessibility, fostering a broader dissemination of knowledge. The journal invites submissions from a diverse range of disciplines, aiming to bridge gaps across fields and encourage interdisciplinary collaboration. By addressing the multifaceted nature of stress, STRESS remains essential for those eager to contribute to this dynamic and critical area of research.

Activitas Nervosa Superior Rediviva is a peer-reviewed journal dedicated to the fields of neuropsychology, physiological psychology, psychiatry, and mental health research. Published by the esteemed SLOVAK ACADEMY OF SCIENCES, INSTITUTE OF NORMAL AND PATHOLOGICAL PHYSIOLOGY, this journal embraces an open-access model, facilitating the dissemination of critical findings and discussions within these evolving fields. With a focus on innovative studies spanning from 2009 to 2024, it provides a vital platform for researchers and professionals seeking to understand the complexities of the nervous system and related disorders. Although currently classified in the fourth quartile across relevant categories including neuropsychology and psychiatric health, the journal’s commitment to publishing quality research contributes significantly to the ongoing discourse among academics and clinicians alike. Activitas Nervosa Superior Rediviva invites scholars to engage with its content and further strengthen the integration of research and practice in mental health and neurological sciences.